Novocure News

NovoCure Analyst Ratings

BenzingaApr 10 08:53 ET

NovoCure Analyst Ratings

BenzingaApr 3 12:42 ET

NovoCure's TTFields Show Promise in METIS Study: Outperform Rating Reaffirmed With Raised Price Target

TipRanksMar 29 03:06 ET

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Argenx Se (ARGX) and NovoCure (NVCR)

TipRanksMar 28 05:01 ET

NovoCure Analyst Ratings

BenzingaMar 27 13:43 ET

Nuanced Phase 3 Results Prompt Cautious Hold Rating for NovoCure's Stock

TipRanksMar 27 11:45 ET

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), CareMax (CMAX) and NovoCure (NVCR)

TipRanksMar 19 08:20 ET

NovoCure Analyst Ratings

BenzingaMar 12 10:22 ET

Buy Rating Affirmed for NovoCure Amid Strong Q4 Performance and Promising Pipeline Developments

TipRanksFeb 25 23:28 ET

NovoCure Analyst Ratings

BenzingaFeb 23 10:59 ET

Piper Sandler Sticks to Its Buy Rating for NovoCure (NVCR)

TipRanksFeb 23 07:33 ET

Buy Rating Affirmed for NovoCure Amid Positive Clinical Results and Solid Financial Performance

TipRanksFeb 23 06:00 ET

NovoCure Analyst Ratings

BenzingaFeb 22 14:20 ET

Piper Sandler Sticks to Their Buy Rating for NovoCure (NVCR)

TipRanksJan 12 07:37 ET

NovoCure's Hold Rating: Balancing Near-Term Challenges With Long-Term Market Potential

TipRanksJan 9 06:33 ET

NovoCure's Strong Q4 Performance and Promising Pipeline Underpin Buy Rating

TipRanksJan 9 05:14 ET

Buy Rating on NovoCure Amid Strategic Restructuring and Promising Clinical Trials

TipRanksDec 1, 2023 08:37 ET

Buy Rating on NovoCure Amid Strategic Reorganization and Growth Prospects

TipRanksNov 29, 2023 05:26 ET

Maintaining Hold on NovoCure Amid Strategic Focus and Cost-Cutting Measures; Price Target Adjusted to $20

TipRanksNov 28, 2023 11:35 ET

Analysts Offer Insights on Healthcare Companies: NovoCure (NVCR), Insmed (INSM) and Bristol-Myers Squibb (BMY)

TipRanksOct 31, 2023 02:50 ET